SCHEMBL2537527

SCHEMBL2537527

O=Cn1cncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14384894 0.72
SCHEMBL14845828 0.69
SCHEMBL1078676 0.69
SCHEMBL9743006 0.67
SCHEMBL10711617 0.67
SCHEMBL9245484 0.62
SCHEMBL9427892 0.62
SCHEMBL8813819 0.61 ALDH1A1 (0.31)
SCHEMBL13219816 0.59
SCHEMBL74453 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652178-B1 BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2024-01-24 EP claimed
CN-119032096-A Heterocyclic compounds and their use 金橘生物科技公司 2024-11-26 CN disclosed
US-20240368191-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2024-11-07 US disclosed
US-20240199587-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2024-06-20 US disclosed
US-20240116951-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2024-04-11 US disclosed
EP-4326714-A1 HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2024-02-28 EP disclosed
CN-117295726-A Heterocyclic compounds 豪夫迈·罗氏有限公司 2023-12-26 CN disclosed
CN-115873000-A Isoquinolone and quinazolinone compounds, and composition and application thereof 中山医诺维申新药研发有限公司 2023-03-31 CN disclosed
WO-2022223750-A1 HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2022-10-27 WO disclosed
EP-3694858-A1 BICYCLIC COMPOUNDS FOR USE AS RIP1 KINASE INHIBITORS H. Hoffnabb-La Roche Ag (CH) 2020-08-19 EP disclosed
WO-2009087664-A1 PROCESS FOR PREPARING CHEMICALLY AND CHIRALLY PURE SOLIFENACIN BASE AND ITS SALTS CADILA HEALTHCARE LIMITED (IN) 2009-07-16 WO disclosed
US-20070099956-A1 Nitrogen-containing heterocyclic derivatives having 2, 6-disubstituted styryl ASTELLAS PHARMA INC. AND KOTOBUKI PHARMACEUTICAL CO., LTD. 2007-05-03 US disclosed
EP-1602645-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE HAVING 2,6-DISUBSTITUTED STYRYL Astellas Pharma Inc. (JP) 2005-12-07 EP disclosed
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
CN-1422269-A 1H-imidazopyridine derivatives HOKURIKU PHARMACEUTICAL (JP) 2003-06-04 CN disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed
EP-0613890-A1 Novel triazole compound, process for preparing the same and antifungal agent containing the same NIHON NOHYAKU CO., LTD. (JP) 1994-09-07 EP disclosed
EP-0158741-A2 Intermediates for fungicidal triazole and imidazole compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-10-23 EP disclosed
US-4301166-A FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1981-11-17 US disclosed
US-4239765-A ANTIMYCOTIC AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1980-12-16 US disclosed